Mount Tam Biotechnologies Announces TAM-03, a Novel Compound with Potential to Treat a Range of Cancer Types
Cerulean Announces Oral Presentation of CRLX101 Clinical Data at Gynecologic Oncology 2016 Conference
Arrowhead Pharmaceuticals Presents Promising ARC-520 Hepatitis B Data at The International Liver Congress™ 2016
Rosetta Genomics Granted US. Patent Allowance for Use of Gene Expression Signature for Classification of Kidney Tumors
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
